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EFFECTIVENESS AND RESIDUAL ACTIVITY COMPARISON OF
GRANULAR FORMULATIONS OF INSECT GROWTH REGULATORS
PYRIPROXYFEN AND S-METHOPRENE AGAINST FLORIDA
MOSQUITOES IN LABORATORY AND OUTDOOR CONDITIONS
JAI K. NAYAR,' ARSHAD ALI2 rNo MORTEZA ZAIM3
ABSTRACT. Effectiveness and residual activity tests of granular formulations of 2 insect growth regulators
(IGRs), s-methoprene and pyriproxyfen, against laboratory-reared larvae of 5 colonized mosquitoes, Aedes ae-
gypti, Aedes albipictus, Aides taeniorhynchus, Anopheles quadrimaculatus, and Culex nigripalpas, were con-
i""t"O i" the laboratory and outdoors in plastic tubs. Culex quinquefasciatas was exposed to these two IGRs in
the laboratory only. Each IGR formulation was applied at 0.02 and 0.05 ppm active ingredient (AI) against 5
of the 6 mosquito species both in the laboratory and the outdoor evaluations, whereas Cx. quinquefasciatus was
exposed to 0.2 and 0.4 ppm AI of s-methoprene, and 0.1 and 0.2 ppm AI of pyriproxyfen in the laboratory. s-
Methoprene at 0.02 and 0.05 ppm AI resulted in variable levels (<39-1007o) of inhibition of adult emergence
in the 5 species monitored for 6 weeks after treatment under both test conditions. Aedes taeniorhynchus was the
most susceptible to s-methoprene in terms of initial and residual activity. Culex quinquefasciatus and Ae- al-
bopictus wire the most tolerant to .r-methopene, with maximum emergence inhibitions amounting to 84V" in Cx-
qiinquefasciatus at O.4 ppm and 44.3V" in Ae. albopictus at 0.05 ppm during the lst week in the laboratory'
iyriproiyfen at comparable treatment rates to .r-methoprene caused very high levels (>80-1007o in most cases)
oi itritlut--d residuai emergence inhibitions of the tested species in the laboratory as well as outdoors' In several
species, pyriproxyfen induced complete inhibition of adult emergence for several weeks after treatment, even at
the lowei rate of 0.02 ppm. The World Health Organization has recently recommended the use of pyriproxyfen
for the control of some mosquito species at specified rates in certain habitats.
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INTRODUCTION
The insect growth regulator (IGR) pyriproxyfen
is a juvenile hormone mimic that is highly active
against a wide variety of insects of public health
importance, including fleas, tsetse flies, houseflies,
cockroaches, imported fire ants, chironomid midg-
es, and mosquitoes (Hirano et al. 1998). Because
of the reported excellent activity of the earlier for-
mulations of pyriproxyfen against mosquitoes in
numerous laboratory and field studies worldwide
(Hirano et al. 1998), a granular formulation of this
IGR containing 0.57o active ingredient (AI) was
submitted by Sumitomo Chemical Company, Japan,
to the World Health Organization Pesticide Evalu-
ation Scheme (WHOPES) for testing and evalua-
tion against mosquitoes. This paper contains the re-
sults of this evaluation conducted in Florida and
simultaneously compares the results with the activ-
ity of a granular formulation of the IGR ^t-metho-
prene containing l.5Vo AI. The IGRs were tested at
2 equivalent concentrations against laboratory-
reared larvae of colonized mosquito species in the
laboratory as well as in plastic tubs placed outdoors
I University of Florida, IFAS, Florida Medical Ento-
mology Laboratory, 200 9th Street SE, Vero Beach, FL
32962.
' University of Florida, IFAS, Mid-Florida Research
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tion Scheme, CH-1211, Geneva 27, Switzerland.
for their immediate effectiveness and long-term re-
sidual activity.
MATERIALS AND METHODS
Mosquito species: Laboratory-reared late 3rd-
and early 4th-stage larvae of Aedes aegypti (Lin-
naeus) (colonized in 1982, Florida Medical Ento-
mology Laboratory [FMEL], Vero Beach, FL),
Aedes alboplcras (Skuse) (colonized in 1992,
Gainesville, FL), Aedes taeniorhynchas (Wiede-
mann) (colonized in 1965, FMEL, Vero Beach,
FL), Anopheles quadrimaculatus (Say) (colonized
in 1950, Malaria Research Center, Tallahassee, FL),
Culex nigripalpus Theobald (colonized in 1997,
FMEL, Vero Beach, FL), and Culex quinquefascia-
tus Say (colonized in 1997, FMEL, Vero Beach,
FL) were used.
Test IGRs: Pyriproxyfen (Sumilarv O.5Vo G,lot
5O99X92, Sumitomo Chemical Co., Ltd., Osaka,
Japan), supplied through WHOPES, and s-metho-
prene (Altosid@ XR-G, 1.57o Al, supplied by Well-
mark International, Dallas, TX) were tested.
Laboratory evaluations : These evaluations were
conducted in white polyethylene trays (46 x 38 X
8 cm), lined with 2-mil-thick polyethylene sheets,
containing 6 liters of well water and maintained at
25 1- loc in a rearing room (Nayar et al. 1998).
One hundred late 3rd- and early 4th-stage larvae of
a mosquito species were introduced into each tray
along with 200 mg of larval food (6:1 yeast and
beef liver powder). After 2-3 h of larval acclima-
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tion, the trays were randomly treated. Each IGR
formulation was applied at O.O2 and 0.05 ppm AI
against all mosquito species except for Cx. quin-
quefasciatus, which was exposed to O.2 and 0.4
ppm AI of s-methoprene, and 0.1 and 0.2 ppm AI
of pyriproxyfen. Because of the percent AI differ-
ence in the 2 test formulations, different amounts
(by weight) of the 2 formulations were needed to
achieve the required ppm AI concentrations of each
IGR. Three replicates of each treatment and 3 un-
treated trays to serve as controls were maintained
for each species. Al1 trays were examined daily to
score posttreatment larval and pupal mortality or
survivorship, and adult emergence. A large pipette
was used to collect live pupae and dead larvae and
pupae from each tray on a daily basis. The live
pupae were maintained in cups placed in mosquito
cages to check for emergence. Survivorship in the
treated and control trays was determined by count-
ing the number of pupal skins remaining in the cor-
responding cups. After I wk, when all larvae and
pupae had either died or survived as adults in the
control trays, a fresh batch of 100 laboratory-reared
late 3rd- and early 4th-stage larvae of the same
mosquito species was introduced to each treated
and control trays (if necessary, dead and live larvae
and pupae were collected from the treated trays and
discarded before the introduction of a 2nd batch of
larvae) and routine daily posttreatment mortality
and survivorship observations were continued. In
this manner, 6 batches (weekly) of mosquito larvae
of a species were introduced to the trays to deter-
mine residual activity of each formulation. Two
hundred milligrams of mosquito larval food was
added to each tray at the time of introduction of
each new batch of mosquito larvae and on alternate
days thereafter.
Outdoor evaluations: These evaluations were
conducted in 1-m-diameter polyethylene tubs, lined
with 2-mil-thick polyethylene sheets, containing
100 liters of well water (Ali et al. 1994). The tubs
were maintained outdoors under a canopy (Sun
canopy, Sunshield II, Powell & Powell Supply
Company, Fuquay Varina, NC) to protect from rain
and direct sunlight. The test procedures, treatment
rates, and daily observations for the 2 IGR formu-
lations against each mosquito species in the tubs
were the sarne as described above for the laboratory
trays, except that I g of the larval food was added
to the tubs at the introduction of each batch of 100
mosquito larvae and on alternate days thereafter.
Each tub was kept covered with fine-mesh plastic
screen to protect from air-borne debris, wild in-
sects, and any oviposition by wild mosquitoes.
Water temperature in the tubs was recorded
throughout an evaluation. Four temperature-record-
ing Onset@ computers (32 K Waterproof Stowaway
TidBit, Onset Computer Corporation, Pocasset,
MA) were randomly submerged in 4 separate tubs.
Minimum and maximum water temperatures in the
tubs recorded daily ranged from 13.4 to 30.2.C dur-
ing the span of these evaluations conducted be-
tween Septembet 1999 and June 2000.
The efficacy of a formulation against a mosquito
species in the trays and tubs was assessed as per-
cent inhibition of adult emergence of the species in
treatments, and adjusted for any larval or pupal
mortalities in corresponding controls with the for-
mula of Mulla et al. (1974):
Vo inhibition of emergence : l0O - 100(T/C),
where T is percent emergence in treated containers
and C is percent emergence in control containers.
Mean percent reductions of adult emergence in
each batch of mosquito species caused by the 2
formulations in trays and tubs were analyzed by l-
way analysis of variance with Tukey-Kramer mul-
tiple comparison posttests by using the computer
software Instat V. 3.00 for Windows (Graphpad
Software, San Diego, CA).
RESULTS AND DISCUSSION
Effectiveness and residual activity of the 2 IGRs
against the test mosquitoes in the laboratory trays
and in tubs outdoors are shown in Figs. I and 2,
respectively. Pyriproxyfen at O.O2 and 0.05 ppm
rates monitored for 6 wk after treatment induced
almost lUOVo emergence inhibition of Ae. aegypti
in the laboratory as well as in the tubs, whereas s-
methoprene was less effective, reducing emergence
of this species 22.3-93.7Vo in the laboratory and
lO.3-lOOVo in tubs, even at the higher rate of 0.05
ppm (Figs. la, 1b). The activity profile of s-meth-
oprene for the lst 2 weeks after treatment in the
laboratory and I wk after treatment in the tubs at
the high rate of 0.05 ppm was similar to that of
pyriproxyfen, but thereafter, pyriproxyfen showed
much higher levels of sustained residual activity
against Ae. aegypti in both test systems. Itoh (1993)
reported that a synthetic slow-release formulation
of pyriproxyfen (0.O57o AI) exhibited prolonged
activity against larvae of Ae. aegypti even when the
treatments were diluted by using and replenishing
water in the treated jars.
The high rate of 0.05 ppm of s-methoprene pro-
duced a maximum of 44.3Vo (in laboratory) and
32Vo (in tubs) emergence inhibition in Ae. albop-
ictus at I wk after treatment (Figs. lb and 2b). In
comparison, pyriproxyfen induced 52.7-lOOVo (at
0.02 ppm) and 93-l0OVo (at 0.05 ppm) emergence
inhibition in the laboratory, and sustained l007o
emergence inhibition in the tubs for 6 wk after
treatment at both treatment rates. Pyriproxyfen
against Ae. albopictus was distinctly superior over
s-methoprene in terms of magnitude and duration
of activity at equal concentrations of active ingre-
dients of the 2 IGRs. These observations concur
with those of the laboratory bioassay study of Ali
et al. (1995), which study showed 21.5 times higher
toxicity of pyriproxyfen against Ae. albopictus than
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Fig. 1. Posttreatment mean 1 SD percent inhibition of adult emergence of laboratory-reared larvae exposed to s-
meth;prene and pyriproxyfen in trays. The larvae of the lst 5 mosquito species were exposed at 0.02 and 0.05 ppm
active ingredient (AI) of each insect gfowth regulator (IGR). *Larvae of Culer quinquefasciat s were exposed to 0.2
and 0.4 ppm AI of each IGR. Means of percent adult emergence inhibition followed by the same letter are not
statistically significant (P > 0.05).
s - Methoprene
0.a2ppnffi 0.05 ppmffi
of s-methoprene, when using the technical grade of
each IGR.
Residual activity of s-methoprene against Ae.
taeniorhynchrr was generally of higher magnitude
and duration in outdoor tubs than in the laboratory
trays (Figs. lc and 2c). The higher rates of s-meth-
oprene did not consistently produce significantly
higher levels of emergence inhibitions in the week-
ly observations, particularly in the tubs. Pyripro-
Pyriproxyfen
0.02 ppm[] 0.05 ppm!
xyfen was superior over s-methoprene, producing
higher levels of emergence inhibitions of Ae. tae-
niorhynchus at O.O2 ppm as well as at 0.05 ppm in
the laboratory and outdoors, specifically during the
3rd to 6th weeks after treatment. No significant dif-
ference (P > 0.05) was found in emergence inhi-
bition of Ae. taeniorhynchus between the low and
the high rates of pryriproxyfen in both test systems.
The previous laboratory study of Schaefer et al.
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Fig. 2. Posttreatment mean :t SD percent inhibition of adult emergence of laboratory-reared larvae of 5 mosquito
species exposed to s-methoprene and pyriproxyfen in tubs outdoors at 0.02 and 0.05 ppm active ingredient (AI) of
each insect growth regulator. Means of percent adult emergence inhibition of a mosquito species followed by the same
letter are not statistically significant (P > 0.05).
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(1988), which showed pyriproxyfen median lethal
concentration and 9O7o lethal concentration values
of 0.01 and 0.052 ppb, respectively, against larvae
of Ae. taeniorhynchus, is indicative of the excellent
activity of this IGR against this mosquito species.
The activity of s-methoprene against Cx. nigri-
palpus lasted for 2-3 wk in the laboratory and for
3-4 wk in the tubs at both rates of treatment (Figs.
ld and 2d). In compaf,ison, pyriproxyfen gave con-
sistently superior results; even the lower rate of this
IGR completely suppressed emergence of Cx. ni-
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gripalpus from the tubs during the 6 wk of obser-
vation.
Against An. quadrimaculqtus, r-methoprene at
0.02 and 0.05 ppm in the laboratory as well as in
the outdoor tubs caused notably lower levels of
emergence inhibition than did pyriproxyfen used at
same concentrations, although these differences
were not statistically significant for the lst week
after treatment in the laboratory and up to the 3rd
week after treatment in the tubs (Figs. le and 2e).
The former IGR in the laboratory resulted in 14-
Ano ph el es qu ad ri m acul atu s
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79.1Vo (at 0.02 ppm) and l9-78.87o (at 0.05 ppm)
emergence inhibition of An. quadrimaculatus dlur'
ing the l-6 wk after treatment, whereas pyripro-
xyfen at O.02 ppm caused 91.3-lOOVo emergence
suppression (lOUVo for the lst 5 wk), and complete
emergence suppression for 6 wk after treatment at
the higher rate of 0.05 ppm. In the outdoor tubs, s-
methoprene was highty effective against An. quad'
rimaculatus for only 2 wk after treatment, whereas
pyriproxyfen at either rate of treatment induced a
complete inhibition of emergence of this mosquito
for at least 5 wk after treatment. The superior ac-
tivity of S-31 183 (pyriproxyfen) over s-methoprene
against An. quadrimaculatus was reported previ-
ously by Estrada and Mulla (1986).
Culex quinquefasciatus was relatively more tol-
erant to ,r-methoprene compared to all other mos-
quito species tested. Even the high rate of 0.4 ppm
of this IGR resulted in 84Vo emergence inhibition
of Cx. quinquefasciatus at I wk after treatment,
with activity rapidly declining in subsequent weeks
of observation (Fig. 1). Pyriproxyfen at 0.1 ppm
and 0.2 ppm (rates lower than s-methoprene) com-
pletely inhibited adult emergence of Cx. quinque-
fasciatus in the laboratory for at least 4-5 wk. Such
activity of pyriproxyfen is compatible with reports
of Adames and Rovira (1993) and Chavasse et al.
(1995) showing good field control of Cx. quinque-
fasciatus with O.5Vo granular and lOVo emulsifiable
concentrate formulations of pyriproxyfen used at
rates of 0.025-0.1 pm AI of the lGR.
s-Methoprene and pyriproxyfen also were tested
for effectiveness and residual activity against lab-
oratory-reared larvae of Ae. albopictus and Cx. ni-
gripalpus of the fleld strains in the laboratory trays
only (data are not included here). The results
showed a trend very similar to that observed for
the larvae from the laboratory colonies of these
species at the same treatment rates. Because meth-
oprene ((rs)-methoprene and s-methoprene) has
been used for mosquito control in Florida for the
past 2 decades, the similarities of susceptibility of
laboratory colonies to the field strains indicated a
lack of any tolerance to .r-methoprene developed by
field populations of Ae. albopictus and Cx. nigri-
palpus in the Vero Beach area of Florida.
This study clearly demonstrated the superior ac-
tivity of pyriproxyfen over s-methoprene, on basis
of equal concentrations of the active ingredient,
against a wide variety of mosquitoes in the labo-
ratory and in experimental tubs placed outdoors. In
a majority of cases, pyriproxyfen at the lower rate
of 0.02 ppm induced complete inhibition of adult
emergence of the tested species for several weeks
after treatment. These results suggested that com-
plete inhibition of adult emergence of these mos-
quitoes may be achieved with rates even lower than
the 0.02 ppm AI of pyriproxyfen. The results of
this study concerning the initial and residual activ-
ity of pyriproxyfen against mosquitoes are in com-
plete agreement with those of several previous in-
vestigations employing pyriproxyfen (O.5Vo G)
against mosquitoes in the genera Aedes, Anopheles,
and Culex at rates ranging from 0.01 to I ppm AI
in a variety of field situations (Kerdpibule 1989,
Kamimura and Arakawa 1991, Okazawa et al.
1991, Thongrungiat and Kanda 1991, Adames and
Rovira 1993, Kawada et al. 1994). Based on the
present results as well as those of other WHOPES-
sponsored pyriproxyfen studies and a thorough lit-
erature review of laboratory and fleld activity of
pyriproxyfen against mosquitoes and aquatic non-
target organisms (Hirano et al. 1998, WHO 2O0l),
WHOPES recently recommended the use of pyri-
proxyfen for the control of some mosquito species
at specified rates in certain habitats (WHO 2001).
Also recently, the Joint FAO/WHO Meeting on
Pesticide Residues has considered that, because of
extremely low toxicity of pyriproxyfen to mam-
mals, pyriproxyfen GR can be safely added to
drinking water at a rate of 0.01 mg Al/liter, for
mosquito control (FAO 2O0l).
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